Infliximab for the treatment of rheumatoid arthritis.
BACKGROUND: Infliximab is a human murine chimeric anti-tumour necrosis factor alpha monoclonal antibody recently approved for the treatment of refractory RA. OBJECTIVES: To assess the efficacy and safety of infliximab for the treatment of rheumatoid arthritis. SEARCH STRATEGY: Electronic databases...
Main Authors: | Blumenauer, B, Judd, M, Wells, G, Burls, A, Cranney, A, Hochberg, M, Tugwell, P |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2002
|
Títulos similares
-
Etanercept for the treatment of rheumatoid arthritis.
por: Blumenauer, B, et al.
Publicado: (2003) -
Etanercept for the treatment of rheumatoid arthritis
por: Blumenauer, B, et al.
Publicado: (2004) -
Etanercept for the treatment of rheumatoid arthritis.
por: Lethaby, A, et al.
Publicado: (2013) -
Infliximab in the treatment of rheumatoid arthritis
por: A Perdriger
Publicado: (2009-05-01) -
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
por: Jobanputra, P, et al.
Publicado: (2002)